A 74-year-old man was admitted with rhabdomyolysis after undergoing initial treatment for gastrointestinal cancer with irinotecan. The syndrome partially resolved after the discontinuation of all of his usual medications, including his chronic selective serotonin reuptake inhibitor (SSRI). The rhabdomyolysis was exacerbated upon reinitiation of the SSRI and disappeared when the SSRI was discontinued. The combination of irinotecan and SSRI resulted in potentially lethal rhabdomyolysis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.SMJ.0000084311.35864.D6 | DOI Listing |
Publication Analysis
Top Keywords
selective serotonin
8
serotonin reuptake
8
reuptake inhibitor-induced
4
rhabdomyolysis
4
inhibitor-induced rhabdomyolysis
4
rhabdomyolysis associated
4
associated irinotecan
4
irinotecan 74-year-old
4
74-year-old man
4
man admitted
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!